Abeona Therapeutics Inc. (ABEO) stock
ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3027% below fair value
$2.73+0.13 (+5.00%)
Close on Nov 18, 2026Market cap $156.11MP/E –Yield –
Abeona Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Abeona Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $25.52M. For fiscal 2025 it was $5.82M, up 66.3% from the year before. Over ten years it grew 11.0% a year on average. The highest annual figure on record is $10.00M in fiscal 2020.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.82M | +66.3% |
| FY2023 | Dec 31, 2023 | $3.50M | +147.5% |
| FY2022 | Dec 31, 2022 | $1.41M | -52.9% |
| FY2021 | Dec 31, 2021 | $3.00M | -70.0% |
| FY2020 | Dec 31, 2020 | $10.00M | +233.6% |
| FY2018 | Dec 31, 2018 | $3.00M | +258.2% |
| FY2017 | Dec 31, 2017 | $837.00K | -5.8% |
| FY2016 | Dec 31, 2016 | $889.00K | -14.5% |
| FY2015 | Dec 31, 2015 | $1.04M | +12.4% |
| FY2014 | Dec 31, 2014 | $925.00K | -54.7% |
| FY2013 | Dec 31, 2013 | $2.04M | -53.6% |
| FY2012 | Dec 31, 2012 | $4.40M | +139.5% |
| FY2011 | Dec 31, 2011 | $1.84M | +282.3% |
| FY2010 | Dec 31, 2010 | $481.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.38M | +2745.0% |
| Q1 FY2026 | Mar 31, 2026 | $8.72M | – |
| Q4 FY2025 | Dec 31, 2025 | $5.42M | – |
| Q3 FY2025 | Sep 30, 2025 | $0 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $400.00K | +488.2% |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $3.50M | +911.6% |
| Q4 FY2022 | Dec 31, 2022 | $68.00K | -97.7% |
| Q3 FY2022 | Sep 30, 2022 | $0 | -100.0% |
| Q2 FY2022 | Jun 30, 2022 | $1.00M | – |
| Q1 FY2022 | Mar 31, 2022 | $346.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $3.00M | +522.4% |
| Q3 FY2020 | Sep 30, 2020 | $7.00M | +309.6% |
| Q2 FY2019 | Jun 30, 2019 | $0 | -100.0% |
| Q1 FY2019 | Mar 31, 2019 | $0 | -100.0% |
| Q4 FY2018 | Dec 31, 2018 | $482.00K | +124.2% |
| Q3 FY2018 | Sep 30, 2018 | $1.71M | +680.4% |
| Q2 FY2018 | Jun 30, 2018 | $276.00K | +27.2% |
| Q1 FY2018 | Mar 31, 2018 | $531.00K | +185.5% |
| Q4 FY2017 | Dec 31, 2017 | $215.00K | -16.0% |
| Q3 FY2017 | Sep 30, 2017 | $219.00K | +19.0% |
| Q2 FY2017 | Jun 30, 2017 | $217.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $186.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $256.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $184.00K | – |
See a number that looks wrong?